Literature DB >> 8272856

The JANUS serum bank.

E Jellum1, A Andersen, P Lund-Larsen, L Theodorsen, H Orjasaeter.   

Abstract

The on-going JANUS project was initiated by the Norwegian Cancer Society in 1973. The serum bank comprises close to 0.5 million serum samples collected from 170,000 donors. From 2-16 consecutive samples are available from each donor. The sera are stored at -25 degrees C. At regular intervals the JANUS-collection is matched against the files of the Norwegian Cancer Registry. From 1973 to 1991 almost 5000 of the donors have developed some form of cancer. Frozen serum samples collected from a few months to 18 years prior to clinical recognition of their disease are consequently available for research purposes. The aim of the JANUS-project is to search in these premorbid sera for chemical, biochemical, immunological or other changes that might be indicative of cancer development at early stages. Gas chromatography-mass spectrometry and two-dimensional protein electrophoresis have been used to evaluate the stability of the frozen sera. Some recent findings are: CA125 is elevated several months prior to diagnosis of ovarian cancer; serum thyroglobulin may be a preclinical tumour marker in subgroups of thyroid cancer; low level of selenium in serum reflects increased risk of thyroid cancer; and raised antibodies in serum against Epstein-Barr virus is a risk factor for development of Hodgkin's disease. On-going research includes trace elements and cancer, and studies on lipid-profiles, diet and cancer. The serum bank may in principle be used for other purposes, e.g. in environmental studies. Analysis of sequential sera may determine chemical substances in the sera that might reflect differences in exposure to environmental pollutants in the period 1973-1991.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8272856     DOI: 10.1016/0048-9697(93)90049-c

Source DB:  PubMed          Journal:  Sci Total Environ        ISSN: 0048-9697            Impact factor:   7.963


  12 in total

1.  Association Between Prediagnostic Serum 25-Hydroxyvitamin D Concentration and Glioma.

Authors:  Victoria Zigmont; Amy Garrett; Jin Peng; Michal Seweryn; Grzegorz A Rempala; Randall Harris; Christopher Holloman; Thomas E Gundersen; Anders Ahlbom; Maria Feychting; Tom Borge Johannesen; Tom Kristian Grimsrud; Judith Schwartzbaum
Journal:  Nutr Cancer       Date:  2015-08-28       Impact factor: 2.900

2.  Competitive learning suggests circulating miRNA profiles for cancers decades prior to diagnosis.

Authors:  Andreas Keller; Tobias Fehlmann; Christina Backes; Fabian Kern; Randi Gislefoss; Hilde Langseth; Trine B Rounge; Nicole Ludwig; Eckart Meese
Journal:  RNA Biol       Date:  2020-06-16       Impact factor: 4.652

3.  Prediagnostic Sex Steroid Hormones in Relation to Male Breast Cancer Risk.

Authors:  Louise A Brinton; Tim J Key; Laurence N Kolonel; Karin B Michels; Howard D Sesso; Giske Ursin; Stephen K Van Den Eeden; Shannon N Wood; Roni T Falk; Dominick Parisi; Chantal Guillemette; Patrick Caron; Véronique Turcotte; Laurel A Habel; Claudine J Isaacs; Elio Riboli; Elisabete Weiderpass; Michael B Cook
Journal:  J Clin Oncol       Date:  2015-05-11       Impact factor: 44.544

4.  Breast cancer, cytomegalovirus and Epstein-Barr virus: a nested case-control study.

Authors:  B Cox; A Richardson; P Graham; R E Gislefoss; E Jellum; H Rollag
Journal:  Br J Cancer       Date:  2010-04-20       Impact factor: 7.640

5.  Longchain serum fatty acids and risk of thyroid cancer: a population-based case-control study in Norway.

Authors:  J P Berg; E Glattre; T Haldorsen; A T Høstmark; I G Bay; A F Johansen; E Jellum
Journal:  Cancer Causes Control       Date:  1994-09       Impact factor: 2.506

6.  Physical Activity and Risk of Male Breast Cancer.

Authors:  Hannah Arem; Louise A Brinton; Steven C Moore; Susan M Gapstur; Laurel A Habel; Kenneth Johnson; Laurence N Kolonel; Valerie A McCormack; Karin B Michels; Howard D Sesso; Giske Ursin; Stephen K Van Den Eeden; Elisabete Weiderpass; Michael B Cook; Charles E Matthews
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-09-24       Impact factor: 4.254

7.  Tobacco and alcohol in relation to male breast cancer: an analysis of the male breast cancer pooling project consortium.

Authors:  Michael B Cook; Pascal Guénel; Susan M Gapstur; Piet A van den Brandt; Karin B Michels; John T Casagrande; Rosie Cooke; Stephen K Van Den Eeden; Marianne Ewertz; Roni T Falk; Mia M Gaudet; George Gkiokas; Laurel A Habel; Ann W Hsing; Kenneth Johnson; Laurence N Kolonel; Carlo La Vecchia; Elsebeth Lynge; Jay H Lubin; Valerie A McCormack; Eva Negri; Håkan Olsson; Dominick Parisi; Eleni Th Petridou; Elio Riboli; Howard D Sesso; Anthony Swerdlow; David B Thomas; Walter C Willett; Louise A Brinton
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-12-16       Impact factor: 4.254

8.  Anthropometric and hormonal risk factors for male breast cancer: male breast cancer pooling project results.

Authors:  Louise A Brinton; Michael B Cook; Valerie McCormack; Kenneth C Johnson; Håkan Olsson; John T Casagrande; Rosie Cooke; Roni T Falk; Susan M Gapstur; Mia M Gaudet; J Michael Gaziano; Georgios Gkiokas; Pascal Guénel; Brian E Henderson; Albert Hollenbeck; Ann W Hsing; Laurence N Kolonel; Claudine Isaacs; Jay H Lubin; Karin B Michels; Eva Negri; Dominick Parisi; Eleni Th Petridou; Malcolm C Pike; Elio Riboli; Howard D Sesso; Kirk Snyder; Anthony J Swerdlow; Dimitrios Trichopoulos; Giske Ursin; Piet A van den Brandt; Stephen K Van Den Eeden; Elisabete Weiderpass; Walter C Willett; Marianne Ewertz; David B Thomas
Journal:  J Natl Cancer Inst       Date:  2014-02-19       Impact factor: 13.506

9.  Selenite Induces Cell Cycle Arrest and Apoptosis via Reactive Oxygen Species-Dependent Inhibition of the AKT/mTOR Pathway in Thyroid Cancer.

Authors:  Zhen Cheng; Shuang Yu; Weiman He; Jie Li; Tianyi Xu; Junyu Xue; Peijie Shi; Shuwei Chen; Yanbing Li; Shubin Hong; Haipeng Xiao
Journal:  Front Oncol       Date:  2021-05-21       Impact factor: 6.244

10.  Association between prediagnostic IgE levels and risk of glioma.

Authors:  Judith Schwartzbaum; Bo Ding; Tom Borge Johannesen; Liv T N Osnes; Linda Karavodin; Anders Ahlbom; Maria Feychting; Tom K Grimsrud
Journal:  J Natl Cancer Inst       Date:  2012-08-01       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.